Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Product Stability01:16

Drug Product Stability

331
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
331
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

438
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
438
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

367
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
367
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

407
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
407
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

476
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
476
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

316
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
316

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.

Emerging microbes & infections·2023
Same author

Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccines.

Vaccine·2023
Same author

Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP <i>Zaire ebolavirus</i> Vaccine to Inform Marburg Virus and <i>Sudan ebolavirus</i> Vaccines.

Vaccines·2022
Same author

Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.

Vaccine·2022
Same author

Fabrication of hydrophobic NiFe<sub>2</sub>O<sub>4</sub>@poly(DVB-LMA) sponge <i>via</i> a Pickering emulsion template method for oil/water separation.

Soft matter·2021
Same author

Enabling Lyophilized Pneumococcal Conjugate Vaccines Through Formulation Design and Excipient Selection Suitable for A Multivalent Adjuvanted Vaccine.

Journal of pharmaceutical sciences·2020

Related Experiment Video

Updated: Mar 16, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K

Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies.

Patrick L Ahl1, Christopher Mensch1, Binghua Hu1

  • 1Vaccine Bioprocess Research and Development, Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania 19486; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey 07033.

Journal of Pharmaceutical Sciences
|August 16, 2016
PubMed
Summary
This summary is machine-generated.

Design of Experiments (DoE) combined with accelerated stability studies effectively predicts vaccine thermal stability. This approach rapidly identifies formulation differences, improving vaccine development, even without full mechanistic understanding.

Keywords:
analytical biochemistrybiotechnologyexcipientsstabilityvaccine adjuvantsvaccines

More Related Videos

Procedure to Evaluate the Efficiency of Flocculants for the Removal of Dispersed Particles from Plant Extracts
10:37

Procedure to Evaluate the Efficiency of Flocculants for the Removal of Dispersed Particles from Plant Extracts

Published on: April 9, 2016

9.3K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.4K

Related Experiment Videos

Last Updated: Mar 16, 2026

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K
Procedure to Evaluate the Efficiency of Flocculants for the Removal of Dispersed Particles from Plant Extracts
10:37

Procedure to Evaluate the Efficiency of Flocculants for the Removal of Dispersed Particles from Plant Extracts

Published on: April 9, 2016

9.3K
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
09:28

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation

Published on: May 18, 2020

9.4K

Area of Science:

  • Vaccine Formulation Development
  • Pharmaceutical Stability Studies
  • Biologics Manufacturing

Background:

  • Vaccine thermal stability is crucial and influenced by formulation factors like pH and excipients.
  • Regulatory approval requires experimental stability data, not just predictions.
  • Predicting stability can be challenging, especially when underlying mechanisms are unclear.

Purpose of the Study:

  • To evaluate the effectiveness of Design of Experiments (DoE) in predicting vaccine thermal stability.
  • To demonstrate the utility of accelerated stability studies in vaccine formulation.
  • To accelerate the preformulation stage of vaccine development.

Main Methods:

  • Utilized a Design of Experiments (DoE) approach.
  • Conducted an accelerated stability study at 37°C.
  • Studied an aluminum adjuvant *Neisseria meningitidis* serogroup B vaccine formulation.

Main Results:

  • DoE successfully described thermal stability in relation to formulation input factors.
  • Accelerated studies at 37°C identified formulation stability differences within 15 days.
  • Empirical understanding of stability was achieved even without complete mechanistic insight.

Conclusions:

  • Combining DoE with accelerated stability studies significantly enhances vaccine formulation development.
  • This integrated approach accelerates the identification of optimal vaccine formulations.
  • The methodology is particularly powerful during the preformulation stage.